Primaquine phosphate how supplied: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Primaquine phosphate}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PRIMAQUINE PHOSPHATE TABLET, FILM ...") |
No edit summary |
||
Line 2: | Line 2: | ||
{{Primaquine phosphate}} | {{Primaquine phosphate}} | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==How Supplied== | |||
Primaquine phosphate is supplied as pink, convex, discoid, film-coated tablets of 26.3 mg (= 15 mg base), printed with a "W" and "P97" on one side. | |||
Available in bottles of 100. (NDC 0024-1596-01) | |||
Store at 25° C (77° F); excursions permitted to 15° C – 30° C (59° F – 86° F) [see USP Controlled Room Temperature] | |||
Dispense in tight, light-resistant container as defined in the USP/NF. | |||
Revision as of 05:33, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
How Supplied
Primaquine phosphate is supplied as pink, convex, discoid, film-coated tablets of 26.3 mg (= 15 mg base), printed with a "W" and "P97" on one side.
Available in bottles of 100. (NDC 0024-1596-01)
Store at 25° C (77° F); excursions permitted to 15° C – 30° C (59° F – 86° F) [see USP Controlled Room Temperature]
Dispense in tight, light-resistant container as defined in the USP/NF.
References
Adapted from the FDA Package Insert.